Exabis Library
Welcome to the e-CCO Library!
P879: Clinical significance of plasma interleukin-22 as a biomarker of inflammation in patients with Crohn's disease and ulcerative colitis
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:12 AM
P879: Colonic mucosa-associated microbiota analysis in newly diagnosed Lithuanian paediatric IBD cases
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P880: Dysbiotic changes caused by polyethylene glycol in ulcerative colitis patients: "Lavage" or intrinsic effect?
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P880: High incidence of inflammatory bowel disease in Northern Australia: a prospective community population-based Australian incidence study in the Mackay-Isaac-Whitsunday region
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:12 AM
P881: Clostridium difficile infection at diagnosis and during the course of paediatric inflammatory bowel disease
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P881: Is occupation a risk factor for developing Inflammatory Bowel Disease? A case-control study.
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:12 AM
P882: Dietary interventions may modify intestinal inflammation via altering microbial composition—a cross-over trial
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P882: Regional differences in biologic and surgical treatment of inflammatory bowel disease in Norway 2011–2019
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:12 AM
P883: Faecal microbiota composition in adult, newly diagnosed, treatment-naïve IBD patients
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P883: Parental and perinatal risk factors associated with onset of Inflammatory Bowel Disease: A systematic literature review and meta-analysis.
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:12 AM
P884: Association between psychosocial factors experienced in childhood or adolescence and occurrence of Inflammatory Bowel Disease (IBD) in adulthood: a case-control study in Quebec, Canada
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:12 AM
P885: Does long term corticosteroid use increase the risk of femur fracture in Inflammatory Bowel Disease patients? : A nationwide population-based cohort study
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:12 AM
P886: Clinical course and therapeutic management 5 years after diagnosis, in a cohort of Spanish patients with Crohn´s disease diagnosed in the 21st century.
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:12 AM
P887: Epidemiology of perianal fistulising Crohn's disease: a systematic literature review
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:12 AM
P888: Evaluating patient access to infliximab subcutaneous in inflammatory bowel disease
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:12 AM
P889: Serologic response with antimicrobial antibodies during the preclinical phase of inflammatory bowel disease
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:12 AM
P890: Prevalence and Characteristics of Extra-intestinal Manifestations in a single cohort of Italian Patients with Inflammatory Bowel Disease
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:12 AM
P891: Estimating diet's quality in patients with Crohn's disease during remission
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:12 AM
P892: Characteristics and trend of Inflammatory Bowel Disease epidemiology for 30 years from 1991 to 2020: A single-center experience analysis in Incheon, Korea
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:12 AM
P893: Budget impact analysis of introducing infliximab subcutaneous for the treatment of Inflammatory Bowel Disease in Latvia
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:12 AM